Liu X, Na R S, Bi Z Q
Chinese Preventive Medicine Association, Beijing 100021, China.
Shandong Center for Disease Control and Prevention, Jinan 250014, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Jul 10;41(7):994-997. doi: 10.3760/cma.j.cn112338-20200216-00108.
An outbreak of severe pneumonia of unknown cause was reported in December 2019 in Wuhan, Hubei province, China. The infectious virus was soon identified and named as 2019 novel coronavirus (2019-nCoV). The name of the COVID-19 was given by WHO on 11 February 2020. It has so far caused about 118 000 cases in 114 countries including China ending March 10, and was characterized as a pandemic by WHO on March 11. We still face great challenges in control of the epidemic: uncertain initial source of infection, infected populations widely scattered, complex routs of transmission, populations generally susceptible, high contagiousness of the virus, and finally vaccines unlikely available in the near future.
2019年12月,中国湖北省武汉市报告了一起不明原因的严重肺炎疫情。这种传染性病毒很快被识别出来,并被命名为2019新型冠状病毒(2019-nCoV)。2020年2月11日,世界卫生组织将其命名为COVID-19。截至3月10日,包括中国在内,该疫情已在114个国家造成约11.8万例感染病例,并于3月11日被世界卫生组织列为大流行病。在疫情防控方面,我们仍面临巨大挑战:感染源最初不明、感染人群广泛分散、传播途径复杂、人群普遍易感、病毒传染性强,且短期内不太可能有疫苗可用。